These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 32451411)

  • 1. Nanomedicine-mediated alteration of the pharmacokinetic profile of small molecule cancer immunotherapeutics.
    Van Herck S; De Geest BG
    Acta Pharmacol Sin; 2020 Jul; 41(7):881-894. PubMed ID: 32451411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in small molecule based cancer immunotherapy.
    Cheng B; Yuan WE; Su J; Liu Y; Chen J
    Eur J Med Chem; 2018 Sep; 157():582-598. PubMed ID: 30125720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer immunotherapy from biology to nanomedicine.
    Abdelbaky SB; Ibrahim MT; Samy H; Mohamed M; Mohamed H; Mustafa M; Abdelaziz MM; Forrest ML; Khalil IA
    J Control Release; 2021 Aug; 336():410-432. PubMed ID: 34171445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STING-Activating Small Molecular Therapeutics for Cancer Immunotherapy.
    Huang C; Tong T; Ren L; Wang H
    Chembiochem; 2024 Oct; 25(19):e202400255. PubMed ID: 38980259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. If small molecules immunotherapy comes, can the prime be far behind?
    Zhang J; Zhang Y; Qu B; Yang H; Hu S; Dong X
    Eur J Med Chem; 2021 Jun; 218():113356. PubMed ID: 33773287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-Molecule Immuno-Oncology Therapy: Advances, Challenges and New Directions.
    Chen S; Song Z; Zhang A
    Curr Top Med Chem; 2019; 19(3):180-185. PubMed ID: 30854972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-molecule in cancer immunotherapy: Revolutionizing cancer treatment with transformative, game-changing breakthroughs.
    Chattopadhyay S; Hazra R; Mallick A; Gayen S; Roy S
    Biochim Biophys Acta Rev Cancer; 2024 Sep; 1879(5):189170. PubMed ID: 39127244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved cancer immunotherapy strategies by nanomedicine.
    Guo S; Feng J; Li Z; Yang S; Qiu X; Xu Y; Shen Z
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(3):e1873. PubMed ID: 36576112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances of biphenyl small-molecule inhibitors targeting PD-1/PD-L1 interaction in cancer immunotherapy.
    Chen R; Yuan D; Ma J
    Future Med Chem; 2022 Jan; 14(2):97-113. PubMed ID: 34870447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining Nanomedicine and Immunotherapy.
    Shi Y; Lammers T
    Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivering safer immunotherapies for cancer.
    Milling L; Zhang Y; Irvine DJ
    Adv Drug Deliv Rev; 2017 May; 114():79-101. PubMed ID: 28545888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation studies of novel small molecule ENPP1 inhibitors for cancer immunotherapy.
    Gangar M; Goyal S; Raykar D; Khurana P; Martis AM; Goswami A; Ghoshal I; Patel KV; Nagare Y; Raikar S; Mukherjee A; Cyriac R; Paquin JF; Kulkarni A
    Bioorg Chem; 2022 Feb; 119():105549. PubMed ID: 34929517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances in Stimuli-Responsive Platforms for Cancer Immunotherapy.
    Li L; Yang Z; Chen X
    Acc Chem Res; 2020 Oct; 53(10):2044-2054. PubMed ID: 32877161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Cell Membrane-Derived Biomimetic Nanotechnology for Cancer Immunotherapy.
    Raza F; Zafar H; Zhang S; Kamal Z; Su J; Yuan WE; Mingfeng Q
    Adv Healthc Mater; 2021 Mar; 10(6):e2002081. PubMed ID: 33586322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicine for Cancer Therapy Using Autophagy: An Overview.
    Kotcherlakota R; Rahaman ST; Patra CR
    Curr Top Med Chem; 2018; 18(30):2599-2613. PubMed ID: 30582477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small Molecules Drive Big Improvements in Immuno-Oncology Therapies.
    Huck BR; Kötzner L; Urbahns K
    Angew Chem Int Ed Engl; 2018 Apr; 57(16):4412-4428. PubMed ID: 28971564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunomodulators targeting the PD-1/PD-L1 protein-protein interaction: From antibodies to small molecules.
    Yang J; Hu L
    Med Res Rev; 2019 Jan; 39(1):265-301. PubMed ID: 30215856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled release of immunotherapeutics for enhanced cancer immunotherapy after local delivery.
    Jin Q; Liu Z; Chen Q
    J Control Release; 2021 Jan; 329():882-893. PubMed ID: 33053396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoscale Metal-Organic Frameworks for Cancer Immunotherapy.
    Ni K; Luo T; Nash GT; Lin W
    Acc Chem Res; 2020 Sep; 53(9):1739-1748. PubMed ID: 32808760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic treatments for metastatic cutaneous melanoma.
    Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.